111 Net Income 2018-2024 | YI

111 net income from 2018 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
111 Annual Net Income
(Millions of US $)
2024 $-9
2023 $-55
2022 $-60
2021 $-105
2020 $-70
2019 $-72
2018 $-55
2017 $-38
111 Quarterly Net Income
(Millions of US $)
2024-12-31 $-3
2024-09-30 $-2
2024-06-30 $-2
2024-03-31 $-2
2023-12-31 $-30
2023-09-30 $-13
2023-06-30 $-8
2023-03-31 $-5
2022-12-31 $-15
2022-09-30 $-14
2022-06-30 $-14
2022-03-31 $-17
2021-12-31 $-19
2021-09-30 $-39
2021-06-30 $-25
2021-03-31 $-22
2020-12-31 $-23
2020-09-30 $-16
2020-06-30 $-13
2020-03-31 $-18
2019-12-31 $-22
2019-09-30 $-17
2019-06-30 $-15
2019-03-31 $-18
2018-09-30 $-18
2018-06-30
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.071B $1.973B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.506B 58.15
Hims & Hers Health (HIMS) United States $12.660B 131.53
Tempus AI (TEM) United States $9.553B 0.00
IRhythm Technologies (IRTC) United States $4.485B 0.00
Inspire Medical Systems (INSP) United States $4.076B 63.69
Privia Health (PRVA) United States $2.775B 189.67
Enovis (ENOV) United States $1.788B 9.97
Clover Health Investments (CLOV) United States $1.598B 0.00
Schrodinger (SDGR) United States $1.586B 0.00
Phreesia (PHR) United States $1.457B 0.00
Omnicell (OMCL) United States $1.423B 25.10
Azenta (AZTA) United States $1.223B 56.85
10x Genomics (TXG) United States $1.173B 0.00
Claritev (CTEV) United States $0.632B 0.00
Fulgent Genetics (FLGT) United States $0.631B 0.00
Butterfly Network (BFLY) United States $0.593B 0.00
Talkspace (TALK) United States $0.534B 159.50
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.384B 0.00
TruBridge (TBRG) United States $0.360B 797.67
Outset Medical (OM) United States $0.311B 0.00
Health Catalyst (HCAT) United States $0.264B 0.00
Nyxoah SA (NYXH) Belgium $0.261B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.200B 0.00
Pulmonx (LUNG) United States $0.137B 0.00
EUDA Health Holdings (EUDA) Singapore $0.136B 0.00
KORU Medical Systems (KRMD) United States $0.125B 0.00
American Well (AMWL) United States $0.105B 0.00
MDxHealth SA (MDXH) Belgium $0.100B 0.00
CareCloud (CCLD) United States $0.085B 3.26
HeartBeam (BEAT) United States $0.057B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
Precipio (PRPO) United States $0.014B 0.00
MSP Recovery (MSPR) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00